CDKN2A and amyotrophic lateral sclerosis: Together, the neuroprotective effects of SecinH3 against neurotoxicity induced by different mutant proteins associated with ALS pathogenesis suggest that the cytohesin–Arf pathway is a promising therapeutic target for ALS.